Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter Open-Label Continuation Study in Moderate to Severe Chronic Plaque Psoriasis Subjects Who Completed a Preceding Psoriasis Clinical Study With Adalimumab

NCT00195676 is registered in ClinicalTrials.gov with Abbott as lead sponsor.

NCT NCT00195676
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00195676 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter Open-Label Continuation Study in Moderate to Severe Chronic Plaque Psoriasis Subjects Who Completed a Preceding Psoriasis Clinical Study With Adalimumab
Lead sponsor
Abbott
Phase
Phase 3
Overall status
Completed
Start date
May 31, 2004
Completion date
October 31, 2009
Enrollment
1,469 (actual)
Sites
104

Conditions

As the registry lists them; a condition with its own page is linked.

psoriasis